Article
Cyclocreatine suppresses prostate tumorigenesis through dual effects on SAM and creatine metabolism
2021-02-26
Abstract excerpt
<h4>ABSTRACT</h4> Prostate cancer is highly prevalent, being the second most common cause of cancer mortality in men worldwide. Applying a novel genetically engineered mouse model (GEMM) of aggressive prostate cancer driven by deficiency of PTEN and SPRY2 (Sprouty 2) tumour suppressors, we identified enhanced creatine metabolism within the phosphagen system in progressive disease. Altered creatine metabolism was...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b36e5b6b-ce06-5ff8-8b4c-2ebe98f519e6
- DOI
- 10.1101/2021.02.26.432994
